Intrinsiqs

Is Theravance Biopharma Inc overvalued?

Theravance Biopharma Inc (TBPH) — key valuation metrics and fundamentals.

No verdict
Price
$17.03
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$882.6M
Dividend yield
0.0%
Return on equity
19.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TBPH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.